#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Param Bhatia Email
Talent Acquisition Consultant . CRISPR Therapeutics
Cambridge, MA
Locationp***********@crisprtx.com
Primary EmailHow to contact Param Bhatia
Join and see Param's contact info for free!p***********@crisprtx.com
GROWJO
The Free Company & People Database
Current Roles
CRISPR Therapeutics
Get all of our best features!
About
CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. Our multi-disciplinary team of world-class researchers and drug developers is working to translate this technology into breakthrough human therapeutics in a number of serious diseases. Our lead programs in beta-thalassemia and sickle cell disease have advanced to IND/CTA-enabling studies with a CTA filing planned by the end of 2017, and we are advancing additional programs in ex vivo and in vivo disease areas. In addition to our fully-owned programs, our strategic collaborations with Bayer AG and Vertex Pharmaceuticals expand our portfolio and enable us with unique capabilities. Through our private financings, partnerships, and IPO we have raised >$400M to fund and accelerate our portfolio. We have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from our scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. Our company is headquartered in Zug, Switzerland with R&D operations in Cambridge, Massachusetts, USA and some business operations in London, United Kingdom.CRISPR Therapeutics Address
105 West First StreetCambridge, MA
United States